UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer Journal article
Chen, Yingqing, Zhang, Mingyu, Wu, Anxin, Yao, Xiaojun, Wang, Qianqian. Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer[J]. Molecules, 2022, 27(21).
Authors:  Chen, Yingqing;  Zhang, Mingyu;  Wu, Anxin;  Yao, Xiaojun;  Wang, Qianqian
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:4.2/4.6 | Submit date:2023/01/31
3039-0164  Molecular Docking  Non-small Cell Lung Cancer  Prmt5  Structure-based Virtual Screening  
Virtual Structure Formation Control via Sliding Mode Control and Neural Networks Conference paper
Qin, Qi, Li, Tie-Shan, Liu, Cheng, Chen, C. L. Philip, Han, Min, Cong, F, Leung, A, Wei, Q. Virtual Structure Formation Control via Sliding Mode Control and Neural Networks[C], GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND:SPRINGER INTERNATIONAL PUBLISHING AG, 2017, 101-108.
Authors:  Qin, Qi;  Li, Tie-Shan;  Liu, Cheng;  Chen, C. L. Philip;  Han, Min; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5 | Submit date:2018/10/30
Formation Control  Virtual Structure  Sliding Mode Control  Neural Networks  
Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme Journal article
Zhong H.-J., Liu L.-J., Chan D.S.-H., Wang H.-M., Chan P.W.H., Ma D.-L., Leung C.-H.. Structure-based repurposing of FDA-approved drugs as inhibitors of NEDD8-activating enzyme[J]. Biochimie, 2014, 102(1), 211-215.
Authors:  Zhong H.-J.;  Liu L.-J.;  Chan D.S.-H.;  Wang H.-M.;  Chan P.W.H.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:27 | Submit date:2018/11/06
Inhibitor  Nedd8-activating Enzyme  Repurposing  Structure-based  Virtual Screening